Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950103-25-014354·Qiming Venture Partners VIII-HC, L.P.
Schedule 13G ownership disclosure
Vor BioPharma Inc
Common Stock, $0.0001 par value per share · CUSIP: 929033207
Event date: 2025-09-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Qiming Venture Partners VIII Investments, LLC
Shares: 414,487.00 · Class: 4.55%
- Qiming Venture Partners VIII-HC, L.P.
Shares: 496,272.00 · Class: 5.44%
- Qiming GP VIII, LLC
Shares: 414,487.00 · Class: 4.55%
- Qiming GP VIII-HC, LLC
Shares: 496,272.00 · Class: 5.44%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950103-25-014354
- Form type
- SCHEDULE 13G
- Filer
- Qiming Venture Partners VIII-HC, L.P.
- CIK
- CIK 1910025
- Filed
- Nov 05, 2025
- Reporting period
- Sep 18, 2025
- Description
- Schedule 13G beneficial ownership